The largest community of pharma leaders

Medable Expands Executive Leadership Team With Clinical Trials Veteran Alison Holland

PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc., a leading provider of a digital trial platform connecting patients, sites, and clinical trial teams, today announced the expansion of its leadership team with the addition of Alison Holland as Head of Virtual Trials. Ms. Holland brings over 30 years of clinical trial experience, most recently as Global VP & General Manager for General Medicine at Covance, a leading global clinical research organization (CRO). She previously led and managed a global business unit in Covance delivering solutions for biotech and biopharma with significant experience in general medicine, cardiovascular and oncology. Ali has managed more than 300 clinical trials, working successfully with biotech organizations as well as global pharma on some of their most critical initiatives.

Throughout her tenure, Ali developed a deep knowledge of the clinical trial process and is driven to leverage her experience to bring much-needed change to the industry. Ali will be instrumental to Medable as the company continues to drive the transformation of outdated manual processes with digital trial efficiencies.

“We’re thrilled to have Ali join the Medable team. With her proven success in clinical trial design and alignment to our vision of transforming outdated analog trials, Ali will be a key factor in the Medable digital trial shift,” said Dr. Michelle Longmire, CEO & co-founder, Medable.

“I’m excited to join the Medable team, as we continue to advance and push the boundaries of digital trials. Digital technologies have the ability to revolutionize clinical trials, and can reduce trial time, improve trial diversity, and enable an era of personalized medicine, which will lead to much broader study access and participation,” said Alison Holland, Head of Virtual Trials, Medable.

See how Medable is improving the patient trial experience with digital trials at these upcoming events:

Medable will also be hosting an Endpoints webinar: “How to run a digital trial and reduce time in development by 50%,” on November 6, 12:00 – 1:00 pm ET.

About Medable

Medable is a privately held, venture-backed company headquartered in Palo Alto, California. Medable is on a mission to get effective therapies to patients faster by dramatically reducing the time from therapeutic development to market realization with digital data capture and real-time analytics that remove the complexities of clinical research to dramatically reduce trial timelines. Medable is pioneering a new category of life science technologies that replace the stagnant and siloed data of traditional ePRO, eCOA, EDC, and eSource with an intelligent and unified end-to-end (E2E) platform for clinical trial execution. Medable’s end-to-end digital trial platform allows patients, healthcare providers, clinical research organizations, and pharmaceutical sponsors to work together as a connected and empowered team in clinical trials and research.

For more information, visit www.medable.com and follow Medable on Twitter: @Medableinc

Source

Recent Articles

AVROBIO to Present at Two Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene...

Global Neurofibromatosis Treatment Drugs Market to Surpass US$ 21,223.7 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)-- #NeurofibromatosisTreatment--The Asia Pacific is expected to witness significant growth...

FDA Approves Nucala as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

LONDON--(BUSINESS WIRE)--GlaxoSmithKline plc (GSK) (LSE/NYSE: GSK) today announced the US Food...

Novocure Honors Mesothelioma Day with Activities to Raise Awareness of Mesothelioma and Support the Community

ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure announced today initiatives to bring attention to...

Veracyte Receives ADLT Status for Envisia Genomic Classifier From Centers for Medicare and Medicaid Services

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Receives ADLT Status for Envisia Genomic...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.